A 27-year-old male schoolteacher presented at 11 PM as an emergency to the casualty department. According to the history taken from his wife, he had been completely well that morning but had returned home early fiom work thinking that he had influenza. He had complained of aches in his muscles and feeling shivery. He had gone to bed and at 8 PM he had told his wife that he was feeling a little better. At 10 PM she found him rambling and incoherent and called a doctor. On examination he was pyrexial (39.5"C, pulse 125 beats/ min, BP 90/60) and there was a faint macular rash on the extremities that blanched on pressure. His conscious level was reduced but there was no neck stiffness and there were no focal neurologic signs. Meningococcal infection was suspected and 4 million units of penicdlin were administered intravenously. Investigations revealed the following: Hb 13.4 g/dL, WBC 3.2 x 109/L, platelets 54 X 10l2/L, Na 143 mmol/L, K 3.6 mmol/L, urea 9.0 mmol/L, HCOT 21 mmol/L. Chest radiography and cranial computed tomography (CT) were normal, and a lumbar puncture performed after the C T scan was also normal, with no inflammatory cells and negative Gram stain. Cerebrospinal fluid culture was sterile but blood cultures taken on adrmssion subsequently grew Neisseria meningitidis type B.
The patient was adrmtted to intensive care and over the next 8 h his condition steady deteriorated, with the development of severe hypotension requiring inotropic/pressor support, oliguria, a widespread purpuric rash, evidence of msseminated intravascular coagulation and progressive hypoxemia such that he required elective intubation and ventilation. His condition then began to stabilize but he required ventilation for a total of 14 days, and temporary hemodialysis for acute renal failure, and suffered ischemic necrosis of two fingers on his left hand and several toes. He eventually left hospital 6 weeks after the initial admission and was able to return to work 3 months later.
Case 2
A 54-year-old female presented with fever and breathlessness and was found to have tuberculous pericarditis. She was treated with antituberculous therapy plus 60 mg of prednisolone daily. Despite this, she developed progressive cardiac failure, and 3 weeks later underwent an uncomplicated pericardectomy. Two days after leaving intensive care she became hypotensive on the general ward. She was transferred back to intensive care and examination revealed the following: temperature 37.2"C, pulse 100 beatdmin, BP 60140, respirations 32/min. Her sternotomy wound was clean and not inflamed, there was dullness and there were coarse crackles at the left base, on cardiovascular examination there was a soft pericardial rub, and she was disorientated but with no focal neurologic signs. Arterial blood gases on air were as follows: pH 7.48, PC02 2.7 kPa, PO2 9.8 kPa, HCOY 19 mmol/L, base excess -6. Chest X-ray showed some atelectasis and a small pleural effusion at the left base. Cardiac tamponade or pulmonary embolism were thought the most likely diagnoses, and urgent echocardiography and right heart catheterization were performed. Echocardiogram showed no tamponade and her right heart catheter revealed the following: central venous pressure (CVP) +1 cm, cardiac output (CO) 8 L/min, systemic vascular resistance (SVR) 400 dyne/s per cm5 (normal 800-1200). The low SVR raised the possibility of underlying sepsis and the patient was treated with intravenous fluids, oxygen, pressor agents and intravenous cefotaxime plus flucloxacdhn. Blood and urine both grew Escherichia coli resistant to ampicillin and sensitive to cefotaxime. The patient made a rapid and complete recovery.
COMMENTS ON CASE REPORTS
These two cases were chosen to highlight hfferent aspects of the clinical presentation of sepsis. In the first case a completely well individual was struck down by infection with a highly virulent organism. There was no doubt over the diagnosis at presentation but despite prompt antimicrobial therapy and supportive intensive care the patient's condition progressed within hours, with the development of multi-organ failure from whch he was lucky to survive. In the second case the infection was acquired in hospital while the patient was being treated for another condition. Ths patient was immunocompromised from corticosteroid therapy and had undergone urinary catheterization after cardiothoracic surgery, both of which are risk factors for infection. Prompt recognition and therapy prevented progression to multi-organ failure. The presentation was obscure and highhghts the fact that sepsis should always be considered in the differential diagnosis of hypotension even, as in this case, if the patient is apyrexial. 
MULTIPLE-CHOICE QUESTIONS

COMMENTS ON MULTIPLE-CHOICE QUESTIONS
Question 1
There has been much debate over the terminology of sepsis during the past decade. Currently accepted terminology and definitions were agreed at a consensus conference of the Society for Critical Care Medicine and the American College of Chest Physicians [l] and are as listed in Table 1 . Thus bacteremia and sepsis are not the same thing, and patients may develop a severe systemic response to a localized infection, namely the systemic inflammatory response syndrome (SIRS). Furthermore, a number of non-infectious inflammatory insults such as pancreatitis, trauma and burns can cause SIRS independently of infection. The exact prevalence of severe sepsis is not known and wdl vary between different patient populations. In recent epidemiologic studies the attack rate for SIRS has been measured at 13.6/1000 hospital admissions [2] . SIRS appears to be responsible for about 10% of adrmssions to intensive care [3] but may develop in up to 68% of patients whilst in the intensive care unit (ICU) [4] . Mortality rates vary from 10-20% for Gram-negative bacteremia, to 30-50% in severe sepsis, to over 70% in refractory septic shock with multi-organ failure.
Early epidemiologic studies identified a predominance of Gram-negative bacterial infections in patients with shock. However, over the past 10 years there has been a shift in the microbiology of hospital infections towards gram-positive bacteria and in most studies Gram-positive bacteria, are now responsible for at least 50% of cases of sepsis [5, 6] . Risk factors for sepsis include hospitalization, immunosuppression, trauma and surgical procedures, and it is not surprising that the majority of cases are nosocomially acquired [7] . Although prompt recognition and treatment of early sepsis may prevent disease progression, once refractory shock is established the mortality is at least 50% and has not been reduced by current therapies.
Question 2
The symptoms of sepsis are non-specific and the diagnosis is frequently not made until hypotension develops. Diarrhea and/or vomiting are frequently seen early in patients with sepsis, and are often dismissed as being due to gastroenteritis. Mental confusion may occur as a result of hypoxia or acidosis, or as part of a 'septic encephalopathy'. In sepsis, increased lactic acid production leads to increased respiratory drive. Thus, in the early stages the patient is often breathless but with normal lungs and a respiratory alkalosis on arterial blood gases. As the disease progresses, these compensatory changes fail and metabolic acidosis with increased serum lactate dominates the picture. It is important to remember that patients with severe sepsis may be hypothermic and that this carries a higher mortality. Ecthyma gangrenosum is a characteristic skin lesion with a black necrotic center seen in neutropenic sepsis and is most commonly due to Gram-negative bacteria, particularly Pseudomonas aeruginosa.
Question 3
The key physiologic change in sepsis is a fall in systemic vascular resistance with microvascular shunting across capillary beds. There is an associated increase in cardiac index to compensate for the lowered systemic resistance but in severe sepsis the effects of cpokines and acidosis may lead to impaired myocardial hnction and so the cardiac index may actually be reduced. Reduced arterial oxygenation and capillary shunting produces tissue hypoxia and anaerobic respiration, adding to lactic acidosis. Despite the need of the tissues for oxygen, capillary bed shunting means that tissue oxygen delivery (and therefore oxygen extraction) is reduced, further exacerbating the tissue hypoxia. Although systemic vascular resistance is low, the response of the pulmonary vascular bed to hypoxia is to constrict, leading to elevated pulmonary vascular resistance.
Question 4
Severe sepsis and multi-organ failure is the end result of a complex interaction of pro-inflammatory and antiinflammatory processes triggered by bacterial products such as endotoxin (hpopolysaccharide, LPS). Following activation of responsive cells (predominantly macrophages, neutrophils and endothelial cells), numerous inflammatory mediators are released, including cytokines (e.g. TNFa, IL-I), activated complement factors, kinins, arachidonate metabolites and platelet-activating factor. O n the vascular endothelium, the end result of these stimuli is the activation of procoagulant activity, whch is one factor contributing to the development of disseminated intravascular coagulation. Endothelial activation and damage also leads to increased neutrophd transmigration into tissues and widespread 'capillary leak'. The migration of activated neutrophils into healthy tissues is a key factor in the pathogenesis of organ failure [6, , and although bacteremia is a common consequence of neutropenia, full-blown septic shock is encountered relatively less often in neutropenic patients. Anti-inilammatory (or counterregulatory) mediators released in sepsis include IL-4, IL-10, IL-13, platelet-derived growth factor-P, IL-1 receptor antagonist (IL-1Ra) and soluble TNF receptors (sTNFR) [9, 12] . IL-10 inhibits the release of both T N F a and IL-1 and is being investigated as a possible therapy for severe sepsis. Nitric oxide (NO) is an endogenous vasodilator synthesized in many cell types, including vascular smooth muscle and endothelium. N O production is increased in sepsis and appears to be responsible, at least in part, for the widespread vasodilatation that is so characteristic in sepsis. Inhibiting NO in sepsis increases SVR and blood pressure but at the expense of impahing tissue oxygenation and cardiac output. Breakdown of gastrointestinal integrity is common in severe illness, including sepsis, and may allow bacteria or bacterial products to enter the systemic circulation thus bypassing the liver (bacterial translocation). In experimental models this may precipitate or exacerbate sepsis but the clinical importance of t h s in humans is not known.
Question 5
LPS is one of the best recognized causes of sepsis. LPS is found as an integral component of the outer leaflet of the cell wall of all Gram-negative bacteria. Lipid A is a unique d-glucosamine-based phospholipid that is highly conserved across Gram-negative bacteria. Lipid A is covalently linked to a relatively conserved core oligosaccharide and then to a repeated polysaccharide chain (0 antigen) that varies widely between bacterial strains. In experimental models synthetic lipid A is capable of inducing septic shock. Antibodies directed against the inner core of LPS may protect against challenge with heterologous bacterial strains, but antibodes to the outer 0 antigen only protect against that individual strain. Considerable progress has been made in understanding the basis of cellular activation by LPS. LPS first interacts with a serum protein, lipopolysaccharide-bindmg protein (LBP) [ 131. LBP acts as 'shuttle' presenting LPS to CD14, a glycosylphosphoinositol-linked protein on the surface of neutrophils and macrophages. Endothelial cells do not express CD14 but soluble CD14 is found in the circulation and appears to be able to mediate endothelial responses to LPS [14] . The currently favored hypothesis is that CD14 is not itselfa signaling receptor but mediates the interaction between LPS and an as yet unidentified signaling molecule [15, 16] . The elucidation of these events wdl hopefidly lead to specific antiendotoxin therapeutic strategies in the near hture [171.
Question 6
TNFa is one of the central inflammatory cytolunes in the host response to infection and in the pathogenesis of sepsis [18, 19] . T N F a is released in vim, by macrophages and neutrophils in response to LPS or products h m Gram-positive bacteria. In human volunteers T N F a appears in the circulation 2 to 4 h after endotoxin challenge [20] , and T N F a can induce all of the features of septic shock in experimental animals. T N F a has pleotropic inflammatory actions, includmg enhancing neutrophd adherence to endothelium by upregulation of both neutrophil and endothelial adherence molecules. After cellular activation TNFa receptors are proteolytically cleaved from the cell surface and appear in the circulation. These soluble T N F a receptors (sTNFR) bind to and neutrahze free TNFa, thus acting as an endogenous T N F a regulatory mechanism. Chimeric forms of the sTNFR bound to the Fc portion of human IgG effectively neutralize T N F a in vitro and are under trial in the treatment of severe sepsis. Among other actions, T N F a induces a catabolic state (originally T N F a was called TNF/ cachectin) and also inhibits myocardial contractility [21] .
Question 7
Staphylococcal toxic shock syndrome is characterized by fever, diarrhea, hypotension, a macular rash which later desquamates on the palms and soles, and organ failure in the context of infection with a toxin-producing strain of Staphylococcus uureus. The staphylococcal infection may be generalized, but more commonly is focal, usually a wound infection or vaginal colonization at the time of menstruation. About 50% of cases are menstrually associated, with the remainder evenly divided between males and females. Toxic shock syndrome toxin-1 (TSST-1) is thought to act as a superantigen [22] . Superantigens are able to directly activate T-cells by binding to both the MHC I1 molecule on antigen-presenting cells and the Vp subunit of the T-cell receptor. Thus, all T-cells with a compatible Vp subunit can be activated, and this can be up to 20% of the T-cell population, resulting in widespread immune stimulation [23] . Superantigenic toxins have also been isolated from other staphylococci and some strains of streptococci. The mortality of toxic shock is less than lo%, in contrast to the 30-50% mortality of Gram-negative septic shock.
Question 8
Treatment of Gram-negative bacteria with certain antibiotics leads to release of fiee LPS, and in some experimental animals this may exacerbate or even trigger severe sepsis [24] . In childhood meningitis there is evidence that postantibiotic release of LPS may increase inflammatory indices in the cerebrospinal fluid, but in sepsis it has been ddkult to prove that this is a clinically relevant phenomenon. Therefore, until such convincing data are available, antibiotics should be chosen for their efficacy against the likely infecting pathogens rather than on the theoretical consequences of endotoxin release. The cardiac index is impaired in many patients with sepsis and may be improved by dobutamine. Noradrenaline and other pressor agents may be required to increase systemic vascular resistance where vital organ function is threatened by hypotension, but may impair renal perfbsion and precipitate renal failure. Therefore, a low SVR needs to be interpreted in the context of the clinical picture, and noradrenaline should be used cautiously. Many antiinflammatory strategies have been investigated in sepsis or are under evaluation [17] . Corticosteroids protect animals from subsequent endotoxin challenge, and after some promising human studies corticosteroids were used in many centers in all septic patients. However, large controlled studies and two meta-analyses have failed to show any benefit from corticosteroids and, indeed, there is a slightly increased mortality as a result of secondary infections [25, 26] . Therefore, with the exception of the special case of toxemic typhoid fever, the routine use of corticosteroids in sepsis cannot be supported. 
